Business ❯ Pharmaceutical Industry

Market Competition

Drug Pricing Novo Nordisk Pricing Strategies Eli Lilly Drug Sales Weight Loss Drugs Drug Development Drug Launches Drug Approval Generic Drugs Product Launches Obesity Drugs Stock Performance Stock Market Product Development Drug Distribution Bidding Wars Drug Approval Process Investment Strategies Obesity Treatments Weight Loss Market GLP-1 Drugs Pain Relief Products Acquisitions Generic Drug Market Drug Manufacturing Pricing Agreements Vaccine Market Regeneron Pharmaceuticals Consumer Behavior Compounding Pharmacies Novo Nordisk vs Eli Lilly Generic Medications Biologics Market Weight Loss Medications Drug Approvals Injectable Therapies Eli Lilly vs Novo Nordisk Research and Development Telehealth Services Pricing Branding Drug Alternatives Drug Efficacy Weight Loss Drug Market RSV Vaccines GLP-1 Market Anti-Obesity Drugs Product Launch Product Hop Regulatory Measures Drug Launch Investor Relations CGRP Inhibitors Monopolies Investor Expectations Weight-loss Drugs

Strive Compounding Sues Lilly and Novo, Alleging Antitrust Push to Block Compounded GLP-1s

The filing spotlights alleged telehealth exclusivity following FDA curbs on semaglutide compounding.

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Indiana Sues Eli Lilly, Alleging Scheme to Inflate Insulin Prices

FDA Approves Novo Nordisk’s Wegovy Pill, First Oral GLP-1

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

Novo Nordisk Files FDA Application for Weekly CagriSema Obesity Shot as GLP-1 Competition Intensifies

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

Lilly Cuts Zepbound Cash Prices on LillyDirect as GLP‑1 Price Competition Deepens

FDA OKs RVO Use and Monthly Dosing for Regeneron’s Eylea HD

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions

FDA Approves Keytruda QLEX, a Rapid Subcutaneous Option for Most Adult Solid Tumor Uses

FDA Approves Weekly Leqembi Autoinjector for At-Home Maintenance in Early Alzheimer’s

FDA Approves Ionis’ Dawnzera to Prevent Hereditary Angioedema Attacks